This study aims to use a two arms randomized clinical trial study to evaluate the effectiveness of the effective constituent of Mukbang in helping children with cancer hospitalized for radiotherapy and chemotherapy to improve their appetite, nutritional status and quality of life.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Self-reported appetite during the intervention
Timeframe: Change from baseline appetite during 7 days intervention
Self-reported appetite during the intervention
Timeframe: Change from baseline appetite at 4 weeks follow-up